Responses to peginterferon alfa-2a vs alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C

Introduction: The WHO estimates that 180 million people are chronically infected with hepatitis C virus (HCV) throughout the world. Despite the emergence of new therapies, the combination of pegylated interferon and ribavirin remains the accepted standard of care in low-income countries, including M...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Jorge Luis Sandoval-Ramirez, José Antonio Mata-Marín, Gloria Huerta García, Jesús Enrique Gaytán-Martínez
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	The Journal of Infection in Developing Countries 2015-03-01
श्रृंखला:	Journal of Infection in Developing Countries
विषय:	genotype 1 treatment sustained virological response anemia relapse
ऑनलाइन पहुंच:	https://jidc.org/index.php/journal/article/view/5284
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!